Sponsor Pipeline

Shanghai AbelZeta Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
5
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 1/2
3
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05521802 A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma Multiple Myeloma Recruiting
NCT05800977 A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory… Relapsed/Refractory Large B-Cell Lymphoma Recruiting
NCT06590246 A Study to Evaluate C-CAR031 in Glypican-3 (GPC3)+ Advanced/Recurrent Hepatocellular… Hepatocellular Carcinoma Recruiting
Phase 1
NCT07444281 An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+… Squamous Cell Lung Cancer Recruiting
NCT07344311 A Phase I Trial of A-CAR032 in Participants With mCRPC Prostate Cancer Recruiting
Disease Areas
Get alerts when Shanghai AbelZeta Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free